54 323 (Methotrexate 2.5 mg)

Pill imprint 54 323 has been identified as Methotrexate sodium 2.5 mg.

Methotrexate is used in the treatment of rheumatoid arthritis; psoriasis; psoriatic arthritis; uveitis; acute lymphoblastic leukemia (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 54 323

Methotrexate sodium 2.5 mg 54 323
Methotrexate sodium 2.5 mg 54 323
Methotrexate sodium 2.5 mg 54 323
Methotrexate sodium
Imprint:
54 323
Strength:
2.5 mg
Color:
Yellow
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-4550
Inactive Ingredients:
lactose
magnesium stearate
corn starch
sodium hydroxide
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00054-8550 Roxane Laboratories,Inc.
23490-5889 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)